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Background: The study of non-atopic asthma/wheeze in children separately from atopic asthma is relatively recent.
Studies have focused on single risk factors and had inconsistent findings.
Objective: To review evidence on factors associated with non-atopic asthma/wheeze in children and adolescents.
Methods: A review of studies of risk factors for non-atopic asthma/wheeze which had a non-asthmatic comparison
group, and assessed atopy by skin-prick test or allergen-specific IgE.
Results: Studies of non-atopic asthma/wheeze used a wide diversity of definitions of asthma/wheeze, comparison
groups and methods to assess atopy. Among 30 risk factors evaluated in the 43 studies only 3 (family history of
asthma/rhinitis/eczema, dampness/mold in the household, and lower respiratory tract infections in childhood)
showed consistent associations with non-atopic asthma/wheeze. No or limited period of breastfeeding was less
consistently associated with non-atopic asthma/wheeze. The few studies examining the effects of overweight/obesity
and psychological/social factors showed consistent associations. We used a novel graphical presentation of different risk
factors for non-atopic asthma/wheeze, allowing a more complete perception of the complex pattern of effects.
Conclusions: More research using standardized methodology is needed on the causes of non-atopic asthma.
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Asthma is the most common chronic noninfectious dis-
ease of childhood and is estimated to affect 300 million
people worldwide, causing a quarter of a million deaths
and 15 million disability-adjusted life years (DALYs) lost
annually [1]. The prevalence of asthma may have reached
a plateau in many industrialized countries, but appears to
be increasing in many low- and middle-income countries
[2]. Asthma is a complex group of conditions, and efforts
have been made to define phenotypes/endotypes based on
age of onset, duration, severity, presence of allergy and
other factors [3-8]. There is no agreed definition of asthma
for research purposes and different research projects use
different definitions, based on clinical symptoms, ques-
tionnaire data and pulmonary function tests. Asthma
has traditionally been considered an allergic disease, but
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unless otherwise stated.a large proportion of children with asthma do not appear
to be allergic. The proportion of asthma that can be attrib-
utable to atopy varies geographically [9,10], and clinical
features are similar between atopic and non-atopic asthma
[11]. Causation of asthma remains poorly understood with
little consensus about the relative importance of differ-
ent putative causal factors. Most studies have ignored
the distinction between atopic and non-atopic disease
even though these phenotypes are likely to have distinct
causal mechanisms.
Recently, studies have started to investigate separately
risk factors for non-atopic asthma and atopic asthma,
and in so doing have raised at least two additional
methodological challenges: the definition of atopy and
the use of an appropriate comparison group. With re-
spect to atopy, there is a high level of concordance
between the results of skin prick test (SPT) reactivity
and specific IgE (sIgE) to aeroallergens in studies done
in Europe and the USA – many studies have used SPT
for reasons of cost and convenience. However, in low-
and middle-income countries there is often a markedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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specific IgE, particularly in underprivileged populations.
Such an effect may relate to the immune modulatory ef-
fects of chronic infections [12,13] that target allergic ef-
fector responses rather than allergic sensitization. There
is the risk, therefore, that the use of SPT to measure
atopy in such populations may misclassify atopic indi-
viduals (i.e. sIgE+) as non-atopic.
The other important methodological challenge is the
choice of the appropriate comparison group. Studies of
risk factors for non-atopic asthma have used different
comparison groups: some used all non-asthmatic chil-
dren, some atopic asthmatics, and others non-atopic non-
asthmatics. There are substantive consequences to this
choice; this has been discussed elsewhere [14,15].
This is the first systematic review of the evidence for
association between a wide range of risk factors and non-
atopic asthma or wheeze in children and adolescents.
Given the variations in definitions of atopy and in the
comparison groups used, we present the evidence for
consistent associations but do not provide a statistical
summary of these associations.
Methods
Following the reporting guidelines recommended in
PRISMA [16] (Additional file 1), we conducted a sys-
tematic review of the scientific literature to identify
studies that have investigated factors associated with
asthma or wheeze in children and adolescents, including
studies that investigated non-atopic asthma exclusively,
and those presenting results separately for non-atopic
asthma.
Search: The electronic database Medline was searched
by AS. The search covered the period 1972 to February
25thth, 2014. The search algorithm applied in free text
was: ((intrinsic asthma) OR (neutrophilic asthma) OR
(nonatopic asthma) OR (non-atopic asthma) OR ("non
atopic" asthma) OR (nonallergic asthma) OR (non-allergic
asthma) OR ("non allergic" asthma) OR (nonatopic wheez*)
OR (non-atopic wheez*) OR ("non atopic" wheez*)) AND
(risk OR ratio). Reference lists of past reviews or meta-
analyses and of publications retained for review were evalu-
ated also. Articles in English, French, Italian, Portuguese
and Spanish were read in the original language. We
were inclusive in accepting studies with a wide range of
definitions of asthma/wheeze based on clinical symptoms
or questionnaire.
Eligibility criteria: Titles and abstract of the articles
identified with the initial search were screened, and arti-
cles were excluded from further analysis based on title
(not relevant) or abstract (unequivocal presence of ex-
cluding features). Excluding features were: article lan-
guages other than those specified, adult asthma/wheeze,
occupational asthma/wheeze, study designs other thancohort, case–control or cross-sectional designs, genetic
studies, definition of atopy other than measurement of
sIgE, skin-prick test (SPT) or both, and studies without
a non-asthmatic comparison group (i.e., those that did not
compare asthmatics with non-asthmatics or explored risk
factors for exacerbations, severity or mortality in asth-
matic populations). Review and meta-analysis articles were
used as sources of references only. No contact was made
with study investigators.
Articles not excluded in the first screen were read by
one author (AS), and either were excluded based on the
criteria listed above, or had information saved in a work-
ing table including: author(s) name, year of publication,
geographic region, size and age of the study population,
study design, way of ascertainment and definition of the
endpoint (asthma/wheeze), definition of atopy, definition
of comparison group, adjustment for confounding, and
effect measures (see Additional file 2). Any doubts and
uncertainties where discussed with another author (LR).
Results of studies in which only univariate analysis was
performed were included. We considered that no statis-
tically significant association with outcome was found
for those factors for which data were presented in descrip-
tive or univariate tables but were not retained in multivari-
ate analysis.
Risk factors were grouped in domains: family history,
smoking, socioeconomic factors, pregnancy and perinatal
factors, nutritional factors, psychosocial factors and dirt/
infection factors. Because many different exposures were
studied, we present an overview of the results in a sum-
mary figure (Figure 1) using a novel graphic presentation
(Frequency of Risk factors Circles or FRiskC). FRIskCs
displays risk factors as circles of sizes proportional to
the number of studies. For each factor, a colour circle
represents the number of studies that found a statisti-
cally significant association and the grey circle the number
of studies that did not. Domains were colour-coded. Digits
inside the circles are the relevant reference numbers.
Summary measures were not estimated for each factor
because of the diversity of methods used between studies.
Results
The initial search of the literature identified 875 articles,
to which 244 more were added from reference lists of
reviews/meta-analyses and articles retained for review.
After eliminating duplicates and performing the first
screening, based on title or abstract, 95 articles were
retained for full-text reading, after which 52 were ex-
cluded for different reasons and 43 articles were retained
for review (Figure 2).
Figure 1 displays risk factors by domain and whether
the studies showed a statistically significant association;
ORs and 95% CI are shown in Table 1 and Additional
file 2. Of the 30 individual or grouped factors, only three
synthetic 
bedding
farm 
exposure
41
21
21,24,38
21,24
lack of material or infor 
mational support 58
dampness/ 
mold
17,19,22,23,
24,25
disorder 57,58 
rodents 
in  home
14,22
34,35,
36
foetal and post-natal 
growth/birth weight/ 
low infant FEV
pets in 
home
infections in 
pregnancy
13,14,21,31
17,22,
31
endotoxin
exposure
36
siblings / 
17,20,22,
23,24
sleep de
privation
season 
of birth
14,21,24
17,38,
47
21,23,
17,23,24,
51
24
17,18,20,
family history of 
eczema
14,17,18,19,20,
21,22,23
childhood 
lower 
respiratory 
infections
feeding
inadequate house 
excreta disposal
21
14
21
19,21,23,24
22,40 32
personal history of 
rhinitis or eczema
1823
asthma, rhinitis or
21,38
smoking 
parents
19,23,24,44
45,46
38
23
environmental 
smoking
active smoking
52,53 33
54
problems in 
pregnancy
38
parental 
education
19,20,48,49,50
short or no
breast-
18,24
sedentary 
lifestyle
22,38,39
obesity / 
overweight
child 55,56
depression in 
21
39
high CRP 
level
birth order 20,43
pollutants/ 
26,27
daycare
14
42
23
crowdingdirty home 
or school
non specified infec
tions in childhood
14,17,18,28,29,
30
33
non-respir.
infections
childhood
maternal mental 
family 
income
insecticides
Figure 1 Evidence base for increase in non-atopic asthma in the following domains: infections/humidity/dirt (green), history (orange),
nutrition (yellow), psychosocial (violet), smoking (blue), pregnancy and perinatal issues (pink), and socio-economic status (brown);
evidence not found (grey). Risk factors are displayed as circles of sizes proportional to the number of studies. Digits inside the circles are the
relevant reference numbers.
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very consistent associations with non-atopic asthma/
wheeze: family history of asthma, living in a home with
damp or humidity, and history of respiratory infections
in childhood. Another two factors that were investigated
in numerous papers, were consistently not associated with875 articles identified 
through
MEDLINE searching
692  articles screened
628 articles 
excluded based on 
title or abstract
64 full-text articles 
assessed for eligibility
24 full-text articles
excluded
183 reviews and meta-
analyses (20 retained 
for references)
40 articles retained
168  articles identified 
from reviews/meta-
analyses
137 articles screened
3 full-text articles 
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0 articles retained
Figure 2 Flowchart of the search.non-atopic asthma/wheeze: family income and birth order.
For all other factors, either the studies were less numerous
or showed conflicting results.
Family history of asthma, rhinitis or eczema showed a
consistently high and significantly positive association
with asthma or wheeze in eight studies, with magnitudes76 articles identified 
from other sources
31 duplicates
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3  full-text articles 
excluded
51 articles screened
25 duplicates
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28 full-text articles 
assessed for eligibility
23 articles 
excluded based 
on title or abstract
134 articles 
excluded based 
on title or abstract
25  full-text 
articles excluded
3 articles retained
Table 1 Factors associated with non-atopic asthma/wheeze by domain, OR and 95% CI
Reference Domain OR (95% CI)
Grouped risk factors Individual risk factors
History of asthma, rhinitis or eczema
Family history
[14] Family history of asthma, rhinitis or eczema 1.91 (1.25–2.92)
[17] Family history of asthma, rhinitis or eczema 5.4 (2.5–11.7)
[18] Family history of asthma, rhinitis or eczema 4.08 (1.85–9.00)
[19] Family history of asthma, rhinitis or eczema 3.63 (2.33–5.66)
[20] Family history of asthma, rhinitis or eczema 3.45 (1.18–10.10)
[21] Family history of asthma, rhinitis or eczema 3.24 (2.42–4.32)
[22] Family history of asthma, rhinitis or eczema 2.35 (1.23–4.52)
[23] Family history of asthma, rhinitis or eczema 1.74 (1.30–2.32)
Personal history
[23] Personal history of rhinitis 2.49 (2.10–2.95)
[23] Personal history of eczema 2.16 (1.63–2.88)
Infection/humidity/dirt
Dampness/mold
[17] Current damp in the household 2.7 (1.4–5.2)
[19] Current or past damp 1.78 (1.10–2.89)
[22] Current damp in the household 2.45 (1.11–5.40)
[23] Current damp in the household 1.48 (1.06–2.08)
[23] Past damp in household 2.44 (1.73–3.44)
[24] Current damp in the household 2.70 (1.16–6.30)
[25] Current damp in the household 1.54 (1.33–1.77)
Childhood lower respiratory infections
[14] Respiratory symptoms < 8 days 1.54 (1.01–2.36)
[14] Respiratory symptoms≥ 8 days 4.87 (2.26–9.76)
[17] Bronchiolitis 14.5 (7.0–30.0)
[18] Recurrent chest infections 3.99 (1.78–8.92)
[28] Wheezing LRI 4.10 (2.48–6.77)
[29] Seropositivity to Chlamidia pneumonia (in girls) 2.39 (1.25–4.57)
Childhood infections other than LRI
[22] Croup 2.80 (1.44–5.43)
[22] Otitis 1.99 (1.02–3.88)
[31] Anti–A.lumbricoides IgE 3.07 (1.13–8.35)
[17] Ascaris infection 3.1 (1.1–6.6)
Non–specified infections in childhood
[32] 5+ episodes of fever 11.48 (5.95–22.12)
[32] 6+ antibiotic courses 24.29 (11.86–49.76)
Infections in pregnancy
[33] ‘Flu’ during pregnancy 2.28 (1.15–4.52)
[33] Fever during pregnancy 2.18 (0.98–4.86)
Farming exposure
[34] Living in a farm 0.45 (0.32–0.63)
[35] Use of silage 0.55 (0.31–0.98)
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Table 1 Factors associated with non-atopic asthma/wheeze by domain, OR and 95% CI (Continued)
[36] Exposure to farming 0.43 (0.19–0.97)
[14] Daycare 1.52 (1.01–2.29)
Dirty home or school
[14] Infrequent household cleaning 2.49 (1.27–4.90)
[22] Dirty school 2.50 (1.28–4.89)
[23] One–room house 2.24 (1.48–3.39)
[21] Older siblings 0.39 (0.25–0.62)
[39] High CPR 1.45 (1.61–1.81)
Pets in home
[22] Cat or dog when infant 2.17 (1.16–4.04)
[40] Cat and dog in early childhood 3.66 (1.50–8.93)
[14] Rodents in home 1.68 (1.21–2.34)
[42] Sleep deprivation (and asthma at age 6 years) 1.87 (1.08–3.25)
[42] Sleep deprivation (and asthma at age 14 years) 2.18 (1.15–4.13)
Pollutants/insecticides
[20] Insecticide (dichlorodiphenyldichloroetylene) 2.49 (1.00–6.19)
[43] NOx from road traffic 2.4 (1.0–5.6)
Smoking
Smoking parents
[23] Mother smoking during pregnancy 1.43 (1.08–1.89)
[24] Mother smoking during the 1st year of life 1.74 (1.17–2.58)
[19] Mother smoking in general 1.67 (1.04–2.68)
Active smoking
[45] Active smoking by the adolescent 17.1 (4.9–60.1)
[46] Active smoking by the adolescent 3.92 (2.01–7.65)
[23] Environmental smoking 1.63 (1.28–2.09)
Socioeconomic factors
Parental education
[17] High parental education 0.3 (0.1–0.9)
[47] High parental education 0.65 (0.43–0.99)
Nutrition
Obesity/overweight
[22] per 5 units increase of BMI 1.55 (1.02–2.36)
[39] Obesity 2.46 (1.21–5.02)
[21] Sedentary life 1.51 (1.06–2.16)
Breastfeeding
[20] Any breastfeeding 0.34 (0.17–0.69)
[48] Any breastfeeding 0.52 (0.27–0.98)
[49] Any breastfeeding in non–affluent countries 0.69 (0.53–0.90)
[19] Short period of breastfeeding 1.80 (1.11–2.92)
[50] Short period of breastfeeding 2.95 (1.31–6.66)
Pregnancy and perinatal issues
[52]* Lower early fetal growth trajectory 0.90 (0.81–1.00)
[54] Born in autumn 2.35 (1.14–4.83)
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Table 1 Factors associated with non-atopic asthma/wheeze by domain, OR and 95% CI (Continued)
Pregnancy
[33] Threatened abortion/premature labour 1.66 (0.96–2.86)
[33] Exposure to isoxsuprine 1.87 (1.12–3.12)
Psychosocial
Depression in child
[55] Depression in child 2.47 (1.12–5.44)
[56] Depression in child 2.90 (1.46–5.73)
Maternal mental disorder
[57] Maternal anxiety 1.78 (1.24–2.57)
[58] Maternal mental disorder 1.73 (1.17–2.55)
Social support
[58] Informational support 0.60 (0.40–0.90)
[58] Material support 0.63 (0.42–0.95)
*RR (95% CI).
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[14,17-23]. One study also detected risks associated
with a personal history of rhinoconjunctivitis and of
eczema [23].
After family history of asthma, the second most fre-
quently studied risk factor for which a consistent and
positive association with the outcome was found was
presence of damp in the household, either observed cur-
rently [17,22-24], in the past [23], or in either periods
[19,25]. One study detected a non-significant risk [26],
and another showed no effect [27].
Many studies investigated the effect of infections and
related factors. Five studies reported a positive associ-
ation with lower respiratory symptoms or infections
(LRI) in early childhood, including bronchiolitis at age
2 years [17], wheezing LRI at age 1 year [28], recurrent
chest infections at 2 years [18], respiratory symptoms by
4 years of age lasting less than 8 days, or 8 days or more
[14], and, in girls, but not in boys, seropositivity to
Chlamidia pneumoniae at 4 years of age [29]. One study
found no association of non-atopic wheeze at 5 years of
age with wheezy or febrile viral LRI in the first year of
age [30].
The effect of infections in childhood other than lower
respiratory infections was less consistent. A study found
a positive effect of croup and of otitis [22].The presence
of anti-Ascaris lumbricoides IgE was a risk for non-
atopic asthma in one study [31], while in the same study
active infections (i.e., stool positive) with A.lumbricoides
or Trichuris trichiura were not, whereas Ascaris infection
was a risk factor for non-atopic wheeze in another study
[17]. Three studies failed to detect significant risks associ-
ated with diarrhea episodes in infancy [14], heavy parasite
burdens with T.trichiura presently [21], or burden of past
or present infections of different etiologies [13].Unspecified infections, expressed as number of episodes
of fever or number of antibiotic courses in childhood, rep-
resented large and significant risks in one study [32]. ‘Flu’
and fever during pregnancy were also positively associated
with non-atopic asthma [33].
Studies of the effect of farming exposures showed
contradictory results: of five studies identified, three from
Central and Northern Europe reported a significant and
similar protective effect [34-36]. A similar effect as in
the latter study was found in a different analysis in the
same population [37]. Two studies failed to find any ef-
fect of farming exposures [21,24]. The only study that
considered endotoxin exposure found a non-significant
risk [36].
Four studies considered the effect of daycare [14,21,24,38],
but only one showed a significant associated risk [14].
Among other conditions related to or associated with
infections in childhood, presence of visible dirt at home
or school was reported as a risk factor in two studies
with similar results [14,22], but inappropriate household
excreta disposal was not [21]. Crowding was found also
to be significantly associated with asthma [23], whereas,
of the six studies evaluating the effect of sibship size
and birth order [17,20-24], only one found a significant
protective effect of having older siblings [21]. Increased
levels of C-reactive protein (CRP), a marker of systemic
inflammation, yielded a significant risk [39]. Other condi-
tions potentially associated with infections are keeping
household pets [19,21-24,40], the use of synthetic bedding
[41], and the presence of rodents in the household
[14]. Among studies that examined these conditions,
only three detected significant risks, in two, associated
with cats and/or dogs during early life [22,40], and in
one, with rodents [14]. Frequent waking at night dur-
ing the first 3 years of life, possibly related to respiratory
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6 and 14 years [42].
Two studies examined the effects of environmental pol-
lutants and found significant positive associations: prenatal
exposure to the insecticide dichlorodiphenyldichloroety-
lene [20], and exposure in first year of life to NOx from
road traffic [43].
Parental smoking was extensively studied but showed
contradictory findings: statistically significant risks were
detected in 4 of 9 studies [17-21,23,24,38,44]. These in-
cluded maternal smoking during pregnancy [23] or during
the 1st year of life [24], mother smoking in general [19],
and heavily smoking parents (67% among non-atopic asth-
matics vs 40% among non-asthmatics) [44]. Active smok-
ing by the adolescent was identified as a significant risk in
two studies [45,46]. Inconsistent results were reported for
second-hand smoking: one study estimated a risk [23],
whereas another one reported no effect [38].
Among factors representing socioeconomic circum-
stances of the child’s family, parental education was
evaluated in six studies showing conflicting effects:
three studies found no association [14,21,24], two
found a protective effect [17,47], and one found a risk
(parental education level was statistically significantly
higher among non-atopic asthmatic than non-asthmatic
children, 12.2 years vs 12.0 years, P < 0.05) [38]. The
three studies evaluating income showed no significant
effects [21,23,38].
All three studies addressing the effect of obesity/
overweight observed increased risks: with 5 units increase
of BMI [22], obesity [39], and mean BMI percentile (68.5
in non-atopic asthmatic children vs 57.7 in non-asthmatic
children, P < 0.05 [38]). Sedentary lifestyle was identified
as a risk factor [21].
Breastfeeding was investigated in seven studies. Three
observed a significant protective effect of any breastfeed-
ing [20,48] (one study found an association in non-
affluent countries only [49]), and two others found a risk
associated with short period of breastfeeding [19,50]. A
further two studies did not detect a significant effect of
breastfeeding [18,24]. One study did not find an associ-
ation in affluent countries [49].
There was no effect of prematurity [17,23], low birth
weight [24] nor birth weight ≥ 4510 g [51]. However, a
lower early fetal growth trajectory (lower head circumfer-
ence growth velocity between 11 and 18 weeks) [52] and a
lower lung function in early infancy (mean (95% CI)
FEV0.4 123.7 (114.6-133.5) ml in non-atopic wheezers vs
139.0 (132.2-146.2) ml in non-atopic non-wheezers) [53]
were associated with non-atopic wheeze. In a study done
in Northern Europe, being born in the autumn was as-
sociated with an increased risk [54]. Threatened abortions
and exposure to isoxsuprine, a tocolytic drug, were both
independently associated [33].Two studies reported associations with depression in
the child and in both the risk was higher in girls, and
lower and not significant in boys [55,56]. A study reported
the impact of maternal anxiety [57], and another one of
maternal mental disorder [58]. The same study found also
a protective effect of social support, which was highest for
informational support and material support.
Discussion
In summary, 43 studies were identified that investigated
30 grouped or individual risk factors for non-atopic
asthma. Consistent and strong associations with the risk
of non-atopic asthma were observed only for 3 factors:
family history of asthma, rhinitis or eczema [14,17-23],
dampness or mold in the household [17,19,22-25], and
lower respiratory infections in childhood [14,17,18,28,29].
A brief period or no breastfeeding also showed a strong,
albeit less consistent, association. Fewer studies investi-
gated the effects of overweight/obesity and of psycho-
logical or social factors, but those that did showed
consistent findings.
Family history of asthma was consistently associated
with non-atopic asthma, as it has been reported for
atopic asthma [14,19,22,23]. This is in agreement with
genetic studies that have identified SNPs predicting both
atopic and non-atopic asthma, but may also indicate the
effects of a shared environment by families [59].
Equally consistent is the reported association between
non-atopic asthma and indoor dampness or mold in the
household [17,19,22-25], and is consistent with evidence
from studies and meta-analyses showing a wide variety
of respiratory effects of such exposures including the de-
velopment of asthma/wheeze and exacerbations in both
atopic and non-atopic individuals including infants [60].
Several plausible biological mechanisms have been pro-
posed to mediate these effects including the induction
of inflammatory, cytotoxic and immunosuppressive re-
sponses to components of microbes or fungi [60].
Wheezing related to respiratory viral infections in early
life has been linked to the development of asthma at
school age [61-63], although it is still matter of contro-
versy whether lower respiratory tract infections (LRI) and
asthma share a common (genetic) predisposition [64], or
whether LRIs have a causal role in asthma development
through impaired epithelial barrier or anti-viral immune
responses or other underlying mechanisms that cause
damage to, and remodeling of, the airways in susceptible
children [65]. It has been suggested that exposure to an
‘aggressive’ environment, with widespread viral respiratory
infections and high levels of environmental pollution, such
as observed among urban poor populations in Latin
America, may lead to enhanced inflammatory responses
and respiratory symptoms that appear to be dissociated
from atopy [66].
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asthma/wheeze is unclear and may vary according to
type of helminth, age of first infection and infection in-
tensity [67,68]. A consistent observation is the strong
inverse association between active helminth infections
and prevalence of SPT [69,70]. The modulatory effects
of chronic childhood infections such as those caused by
helminths on SPT prevalence [13] may add to the meas-
urement error for atopy, because definitions of atopy
based on SPT in endemic populations may lead to sig-
nificant misclassification of atopy, particularly if sIgE
has better explanatory value for the allergic mechanisms
that mediate atopic asthma.
Farming exposures were protective in some studies
[34-36], although not all studies demonstrated an associ-
ation [21,24].
All but one of the studies that evaluated the number
of siblings failed to find an effect, despite the protective
association frequently detected when asthma (irrespect-
ive of atopy) is considered [71]. The apparent inverse
association with asthma overall might be explained by
the inverse association between a greater number of sib-
lings and prevalence of atopy in populations where most
asthma is atopic. The presence of household pets had no
effect on non-atopic asthma except in two studies [22,40].
Almost all studies evaluating breastfeeding found a
consistent, protective effect on non-atopic asthma
[19,20,48-50] (one study observed an effect only in uni-
variate analysis [18]). Interestingly, all but one studies
found that the effect was on non-atopic but not on
atopic asthma, and one study observed an effect only
on non-atopic asthma in less affluent countries [49].
The role of breastfeeding in causation of asthma re-
mains controversial [72-74], and may differ by atopic
phenotype [49,74].
Surprisingly few studies explored the effects on non-
atopic asthma of obesity/overweight [75]. Studies done,
principally in adults, show that risk is increased particu-
larly among non-atopics [76], as was observed among
children in two of three studies included in the present
review [38,39]. It has been suggested that these effects
may be mediated through factors other than the induction
of eosinophilic airway inflammation [76], and that a state
of systemic inflammation may be a key factor in mediating
the effects of overweight/obesity [75].
The results of parental smoking were contradictory,
reflecting a complex picture of the association of paren-
tal smoking with asthma [77]. Some studies reported a
risk, whereas others did not, which could be a true finding,
or could be explained by parents of asthmatic children
stopping smoking.
Level of parental education showed mixed effects in
some studies [17,38,47], and no effect in others [14,21,24].
No effect of family income was observed [21,23,38].Few studies have examined the associations between
non-atopic asthma and child depression, maternal psy-
chological disorders or social support, but all show an
apparent effect in diverse settings. Two cross-sectional
studies reported an association of depression or abnor-
mal emotional symptoms with non-atopic asthma, but
not with atopic asthma [55,56]. In both studies, the ef-
fect was found in girls, but not in boys, and in one study
it persisted after controlling for abdominal adiposity
[55]. It has been suggested that higher levels of leptin
may link non-atopic asthma with psychological disor-
ders: levels of leptin are elevated in girls with asthma, in
non-atopic-asthmatics, and also in children with symp-
toms of depression [55]. A study found an association be-
tween prenatal maternal anxiety and asthma in childhood,
an effect that was stronger in non-atopics than atopics
and that was greater the more severe the symptoms [57].
Maternal mental disorders, including depression and anx-
iety, were associated, independent of maternal history of
asthma and the child’s age, with both non-atopic and
atopic asthma [58] . An independent protective effect of
social support was found in the same study, but only for
non-atopic wheezing.
This review exposed the wide heterogeneity between
studies with respect to methodology: studies used different
comparison groups (non-atopic non-asthmatic children,
all non-asthmatic children, atopic asthmatic children), dif-
ferent definitions of atopy (skin test positivity to allergens,
presence or levels of allergen specific IgE using different
cut-off points for positivity and different panels of aller-
gens), different definitions of asthma/wheeze (doctor’s
diagnosis of asthma used in some studies may select
more severe cases, whereas use of asthma-related symp-
toms such as wheeze adopted in other studies may lead
to inclusion of milder cases), and different study designs
with different ability to establish causality. Some studies
were underpowered.
Despite the number of studies found, their hetero-
geneity with respect to the above did not allow separate
analyses by specific characteristics (e.g. comparison
group used), nor to explore how much of the variation
is due to the methodological diversity. And yet, a few,
remarkably consistent risk factors (respiratory infec-
tions in childhood, family history of asthma, eczema or
rhinitis, and presence of mold or damp in the house-
hold) were identified.
Strengths and Limitations. We developed a novel
graphic presentation of data, which we believe enhances
the perception of the complex pattern of effects. Given
the highly heterogeneous methodologies used in the
studies, a meta-analysis was not performed even for the
risk factors investigated in a sufficient number of stud-
ies. Maybe the most important finding of this review is
the very marked heterogeneity of methods used in the
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progress in this field.
Conclusion
Research in asthma and the ability to compare between
studies clearly requires a consistent and standardized
methodological approach. Allergen-specific IgE levels seem
to provide a more reliable and stable characterization of
atopy than SPT positivity, particularly in populations living
in low- and middle-income countries where the two mea-
sures are dissociated [12,13], and should, therefore, be
preferably used to define atopic status in studies of asthma
epidemiology. The debate is ongoing on which is the best
comparison group (and on the implications for the inter-
pretation of findings) [14,15].
Recommendations
Research using agreed, rigorous methodology is needed
to elucidate the pattern of association and causal mecha-
nisms underpinning non-atopic asthma.
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